Read this company snapshot
Daily valuation snapshot
Evaxion A/S American Depositary Share: source evidence dated 2026-10-09.
- Daily close (USD)
- $3.07
- Market capitalization (USD)
- $25,604,460.42
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.5
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research EVAX in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research EVAX in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing EVAX with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $3.07 |
| Market capitalization (USD) | $25,604,460.42 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.5 |
No matching rows. Clear the filter to see all records.
Read EVAX's valuation metrics
Company size
Evaxion A/S American Depositary Share's recorded market capitalization is $25,604,460.42. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
EVAX's recorded price-to-book ratio is 1.5. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Evaxion A/S American Depositary Share with Aurora
Use the snapshot above to ask a specific question about EVAX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow EVAX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.